1. Pneumonitis After Precision Oncology Therapies: A Concise Review
   Akash Jain et al, 2018, Journal of Immunotherapy and Precision Oncology CrossRef
2. Drug-Related Pneumonitis in Cancer Treatment during the COVID-19 Era
   Sara Cherri et al, 2021, Cancers CrossRef
3. Interstitial lung disease associated with adjuvant and neoadjuvant chemotherapy in early breast cancer
   Kenji Tezuka et al, 2021, World Journal of Surgical Oncology CrossRef
4. Trastuzumab-Induced Interstitial Pneumonitis
   Kimberly Errisuriz et al, 2023, Cureus CrossRef
5. A Review of Treatment-Induced Pulmonary Toxicity in Breast Cancer
   Hanjie Mo et al, 2022, Clinical Breast Cancer CrossRef
6. Ado-Trastuzumab Emtansine-Induced Pulmonary Toxicity: A Single-Institution Retrospective Review
   Heidi Egloff et al, 2018, Case Reports in Oncology CrossRef
7. Risk Minimization of Antibody–Drug Conjugates in Oncology: A Review
   Fabio A. Lievano et al, 2021, Drug Safety CrossRef
8. Engineering peptide-targeted liposomal nanoparticles optimized for improved selectivity for HER2-positive breast cancer cells to achieve enhanced in vivo efficacy
   Baksun Kim et al, 2020, Journal of Controlled Release CrossRef
9. Evaluation of lung adverse events with trastuzumab using the Japanese pharmacovigilance database
   Yuko Kanbayashi et al, 2022, Medical Oncology CrossRef
10. Drug-induced Interstitial Lung Disease in Breast Cancer Patients: A Lesson We Should Learn From Multi-Disciplinary Integration
    Zijun Zhao et al, 2020, BIO Integration CrossRef
11. African Vegetables (Clerodendrum volubile Leaf and Irvingia gabonensis Seed Extracts) Effectively Mitigate Trastuzumab-Induced Cardiotoxicity in Wistar Rats
    Olufunke Olorundare et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
12. Pneumocystis jirovecii pneumonia in a patient treated with trastuzumab-deruxtecan
    Haneen Mallah et al, 2023, BMJ Case Reports CrossRef
13. Interstitial pneumonitis associated with trastuzumab emtansine
    Ali Alkan, 2019, Journal of Oncology Pharmacy Practice CrossRef
14. Medication-induced Pulmonary Injury: A Scenario- and Pattern-based Approach to a Perplexing Problem
    Shravan Sridhar et al, 2022, RadioGraphics CrossRef
15. Pneumonitis associated with Trastuzumab emtansine in a patient with metastatic breast cancer
    Muzaffer Uğraklı et al, 2022, Journal of Oncology Pharmacy Practice CrossRef
16. Breast cancer and organising pneumonia: the importance of correlating the pathological findings with the clinical and radiological picture
    Paul Griffiths et al, 2018, BMJ Case Reports CrossRef
17. The Spectrum of Drug-Induced Interstitial Lung Disease
    Ankush Ratwani et al, 2019, Current Pulmonology Reports CrossRef
18. The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis – A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up
    Chen-Han Chang et al, 2022, The Breast CrossRef
19. Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)–related interstitial lung disease/pneumonitis—Focus on proactive monitoring, diagnosis, and management
    Sandra M. Swain et al, 2022, Cancer Treatment Reviews CrossRef